Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

NCT07514936 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Acute Myeloid Leukemia (AML)
Elderly Patients

Interventions

DRUG: the standard "3+7" regimen
DRUG: Azacytidine; Cytarabine; Aclacinomycin; Chidamide; Venetoclax; Granulocyte

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]